EconPapers    
Economics at your fingertips  
 

PharmacoEconomics

1997 - 2022

Current editor(s): Timothy Wrightson and Christopher I. Carswell

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.


Volume 40, issue 5, 2022

Exploring the Issues of Valuing Child and Adolescent Health States Using a Mixed Sample of Adolescents and Adults pp. 479-488 Downloads
Donna Rowen, Clara Mukuria, Philip A. Powell and Allan Wailoo
Assessments of the Value of New Interventions Should Include Health Equity Impact pp. 489-495 Downloads
Jeroen P. Jansen, Thomas A. Trikalinos and Kathryn A. Phillips
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches pp. 497-507 Downloads
Elamin H. Elbasha
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal pp. 509-518 Downloads
Sabine E. Grimm, Willem Witlox, Robert Wolff, Annette Chalker, Mickael Hiligsmann, Ben Wijnen, Charlotte Ahmadu, Steve Ryder, Nigel Armstrong, Steven Duffy, Isabel Syndikus, Jos Kleijnen and Manuela A. Joore
Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review pp. 519-558 Downloads
Min Huang, Amin Haiderali, Grace E. Fox, Andrew Frederickson, Javier Cortes, Peter A. Fasching and Joyce O’Shaughnessy
The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England pp. 559-574 Downloads
K. Ray Chaudhuri, A. Simon Pickard, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Yanjun Bao, Julia Sus, Glynn Jones, Christian Ridley, Julia Oddsdottir, Seyavash Najle-Rahim, Matthew Madin-Warburton, Weiwei Xu and Anette Schrag
Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal pp. 575-575 Downloads
Sabine E. Grimm, Willem Witlox, Robert Wolff, Annette Chalker, Mickael Hiligsmann, Ben Wijnen, Charlotte Ahmadu, Steve Ryder, Nigel Armstrong, Steven Duffy, Isabel Syndikus, Jos Kleijnen and Manuela A. Joore

Volume 40, issue 4, 2022

Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions pp. 359-366 Downloads
Olena Mandrik, Chloe Thomas, Sophie Whyte and James Chilcott
Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice pp. 367-378 Downloads
Manuel Gomes, Elizabeth Murray and James Raftery
Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures pp. 379-431 Downloads
Joseph Kwon, Louise Freijser, Elisabeth Huynh, Martin Howell, Gang Chen, Kamran Khan, Shahd Daher, Nia Roberts, Conrad Harrison, Sarah Smith, Nancy Devlin, Kirsten Howard, Emily Lancsar, Cate Bailey, Jonathan Craig, Kim Dalziel, Alison Hayes, Brendan Mulhern, Germaine Wong, Julie Ratcliffe and Stavros Petrou
The EQ-5D-5L Valuation Study in Egypt pp. 433-447 Downloads
Sahar Al Shabasy, Maggie Abbassi, Aureliano Finch, Bram Roudijk, Darrin Baines and Samar Farid
Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia pp. 449-460 Downloads
Kaitlyn Hastings, Clara Marquina, Jedidiah Morton, Dina Abushanab, Danielle Berkovic, Stella Talic, Ella Zomer, Danny Liew and Zanfina Ademi
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine pp. 461-476 Downloads
Zoë Pieters, Benson Ogunjimi, Philippe Beutels and Joke Bilcke
Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures pp. 477-478 Downloads
Joseph Kwon, Louise Freijser, Elisabeth Huynh, Martin Howell, Gang Chen, Kamran Khan, Shahd Daher, Nia Roberts, Conrad Harrison, Sarah Smith, Nancy Devlin, Kirsten Howard, Emily Lancsar, Cate Bailey, Jonathan Craig, Kim Dalziel, Alison Hayes, Brendan Mulhern, Germaine Wong, Julie Ratcliffe and Stavros Petrou

Volume 40, issue 3, 2022

Four Aspects Affecting Health Economic Decision Models and Their Validation pp. 241-248 Downloads
Talitha Feenstra, Isaac Corro-Ramos, Dominique Hamerlijnck, George Voorn and Salah Ghabri
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time pp. 249-256 Downloads
Gemma E. Shields, Becky Pennington, Ash Bullement, Stuart Wright and Jamie Elvidge
Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models pp. 257-268 Downloads
Min Huang, Scott Ramsey, Weiguang Xue, Jipan Xie, James Pellissier and Andrew Briggs
Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations pp. 269-295 Downloads
Sónia Romano, Débora Figueira, Inês Teixeira and Julian Perelman
A Comparison of PROPr and EQ-5D-5L Value Sets pp. 297-307 Downloads
Tianxin Pan, Brendan Mulhern, Rosalie Viney, Richard Norman, Janel Hanmer and Nancy Devlin
Developing the EQ-5D-5L Value Set for Uganda Using the ‘Lite’ Protocol pp. 309-321 Downloads
Fan Yang, Kenneth R. Katumba, Bram Roudijk, Zhihao Yang, Paul Revill, Susan Griffin, Perez N. Ochanda, Mohammed Lamorde, Giulia Greco, Janet Seeley and Mark Sculpher
Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom pp. 323-339 Downloads
Timothy Spelman, William L. Herring, Yuanhui Zhang, Michael Tempest, Isobel Pearson, Ulrich Freudensprung, Carlos Acosta, Thibaut Dort, Robert Hyde, Eva Havrdova, Dana Horakova, Maria Trojano, Giovanna Luca, Alessandra Lugaresi, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Raed Alroughani, Eugenio Pucci, Franco Granella, Jeannette Lechner-Scott, Patrizia Sola, Diana Ferraro, Francois Grand’Maison, Murat Terzi, Csilla Rozsa, Cavit Boz, Raymond Hupperts, Vincent Pesch, Celia Oreja-Guevara, Anneke Walt, Vilija G. Jokubaitis, Tomas Kalincik and Helmut Butzkueven
Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment pp. 341-354 Downloads
Gabin F. Morillon and Thomas G. Poder
Correction to: Contextual Considerations and Recommendations for Estimating the Value of Alzheimer’s Disease Therapies pp. 355-355 Downloads
T. Joseph Mattingly, R. Brett McQueen and Pei-Jung Lin
Correction to: Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment pp. 357-357 Downloads
Gabin F. Morillon and Thomas G. Poder

Volume 40, issue 2, 2022

Future Offspring Costs in Economic Evaluation pp. 141-147 Downloads
Evelyn Verbeke and Jeroen Luyten
Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency pp. 149-156 Downloads
Gemma E. Shields, Mark Wilberforce, Paul Clarkson, Tracey Farragher, Arpana Verma and Linda M. Davies
How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents pp. 157-182 Downloads
Cate Bailey, Kim Dalziel, Paula Cronin, Nancy Devlin and Rosalie Viney
Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review pp. 183-201 Downloads
Thitima Kongnakorn, Grammati Sarri, Andreas Freitag, Kinga Marczell, Paulina Kazmierska, Elizabeth Masters, Vivek Pawar and Xinke Zhang
The Utility of a Rapid Review Evaluation Process to a National HTA Agency pp. 203-214 Downloads
Áine Varley, Lesley Tilson, Emer Fogarty, Laura McCullagh and Michael Barry
The Value of Genomic Testing: A Contingent Valuation Across Six Child- and Adult-Onset Genetic Conditions pp. 215-223 Downloads
Yan Meng, Philip M. Clarke and Ilias Goranitis
Is an Orphan Drug’s Cost-Effectiveness Associated with US Health Plan Coverage Restrictiveness? pp. 225-232 Downloads
James D. Chambers, Nikoletta M. Margaretos, Daniel E. Enright, Rosa Wang and Xin Ye
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS pp. 233-239 Downloads
Megan Perry-Duxbury, James Lomas, Miqdad Asaria and Pieter Baal

Volume 40, issue 1, 2022

Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain pp. 3-5 Downloads
Chris Skedgel
CHEERS to 30 Years of PharmacoEconomics pp. 5-6 Downloads
Richard Milne and Christopher Carswell
In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era pp. 7-11 Downloads
Werner Brouwer, Samare Huls, Ayesha Sajjad, Tim Kanters, Leona Hakkaart- van Roijen and Job Exel
Importance of Patient Involvement in the Value Assessment Process: On the Way Towards Personalised Treatments pp. 7-10 Downloads
Nicole Gusset
Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management pp. 11-38 Downloads
Noman Paracha, Pollyanna Hudson, Stephen Mitchell and C. Simone Sutherland
The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe pp. 13-29 Downloads
Natalie Bohm, Sarah Bermingham, Frank Grimsey Jones, Daniela C. Gonçalves-Bradley, Alex Diamantopoulos, Jessica R. Burton and Hamish Laing
Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates pp. 31-43 Downloads
Laura C. Edney, James Lomas, Jonathan Karnon, Laura Vallejo-Torres, Niek Stadhouders, Jonathan Siverskog, Mike Paulden, Ijeoma P. Edoka and Jessica Ochalek
Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers pp. 39-67 Downloads
C. Simone Sutherland, Pollyanna Hudson, Stephen Mitchell and Noman Paracha
Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review pp. 45-64 Downloads
Thomas Ward, Ruben E. Mujica-Mota, Anne E. Spencer and Antonieta Medina-Lara
A General Public Study on Preferences and Welfare Impacts of Antimicrobial Resistance in the United Kingdom pp. 65-76 Downloads
Maria Veronica Dorgali, Alberto Longo, Caroline Vass, Gemma Shields, Roger Harrison, Riccardo Scarpa and Marco Boeri
Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA) pp. 69-89 Downloads
Noman Paracha, Pollyanna Hudson, Stephen Mitchell and C. Simone Sutherland
Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic pp. 77-90 Downloads
Samare P. I. Huls, Ayesha Sajjad, Tim A. Kanters, Leona Hakkaart- van Roijen, Werner B. F. Brouwer and Job Exel
The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing–Remitting Multiple Sclerosis pp. 91-108 Downloads
Laurenske A. Visser, Marc Folcher, Claudia Delgado Simao, Biotza Gutierrez Arechederra, Encarna Escudero, Carin A. Uyl- de Groot and William Ken Redekop
Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom pp. 91-102 Downloads
Siu Hing Lo, Ksenija Gorni, C. Simone Sutherland, Yasmina Martí, Andrew Lloyd and Noman Paracha
Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries pp. 103-115 Downloads
Siu Hing Lo, Claire Lawrence, Yasmina Martí, Andreia Café and Andrew J. Lloyd
Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations pp. 109-120 Downloads
Daniel Gallacher, Peter Kimani and Nigel Stallard
Correction to: Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain pp. 117-117 Downloads
Chris Skedgel
Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA) pp. 119-119 Downloads
Noman Paracha, Pollyanna Hudson, Stephen Mitchell and C. Simone Sutherland
An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia pp. 121-131 Downloads
Marjanne A. Piena, Natalie Houwing, Carla W. Kraan, Xiaofeng Wang, Heidi Waters, Ruth A. Duffy, Suresh Mallikaarjun and Craig Bennison
Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery pp. 133-135 Downloads
Kevin M. Trentino, Hamish Mace and Axel Hofmann
Authors’ Response to “Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery” pp. 137-138 Downloads
Bert Avau, Hans Van Remoortel, Emmy De Buck, Veerle Compernolle and Philippe Vandekerckhove
Correction to: A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population pp. 139-139 Downloads
Emily McDool, Clara Mukuria and John Brazier
Page updated 2022-05-22